During the past decade, Capital Clinical Research Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Clinical Research Associates" #1 sponsor was "Cephalon" with 2 trials, followed by "Forest Laboratories" with 2 trials sponsored, "Massachusetts General Hospital" with 2 trials sponsored, "Avera Pharmaceuticals" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Clinical Research Associates" #1 collaborator was "BrainCells Inc." with 2 trials as a collaborator, "Clinical Associates Research, Maryland" with 1 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator, "Harvard University" with 1 trials as a collaborator and "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Capital Clinical Research Associates" are "Major Depressive Disorder" (5 trials), "Anxiety Disorder" (1 trials), "Bipolar Disorder" (1 trials), "Bipolar I Depression" (1 trials) and "Fibromyalgia" (1 trials). Many other conditions were trialed in "Capital Clinical Research Associates" in a lesser frequency.

Most popular intervention types in "Capital Clinical Research Associates" are "Drug" (11 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "placebo" (2 trials), "AV608" (1 trials), "Armodafinil" (1 trials) and "BCI-024 (Buspirone)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Clinical Research Associates" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Capital Clinical Research Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Capital Clinical Research Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Capital Clinical Research Associates, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".